Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 10:19 PM
NCT ID:
NCT04688658
Group ID:
EG001
Title:
Duvelisib (25mg) + Nivolumab (240mg)
Description:
Phase 1:
Duvelisib, 25mg once a day, 12 hours a part, to determine the recommended dose for the Phase II study when combined with nivolumab.
Nivolumab, 240mg, IV, every 2 weeks for the first four cycles; thereafter it may be switched to 480mg, IV, once every 4 weeks (if deemed appropriate by the study doctor)
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
6
Other Number Affected:
6
Other Number At Risk:
6
Study:
NCT04688658
Results Section:
NCT04688658
Adverse Events Module:
NCT04688658